Background: VPS45 deficiency is an ultra-rare autosomal recessive primary immunodeficiency characterized by severe congenital neutropenia, progressive bone marrow fibrosis, recurrent infections, and multiorgan involvement. Hemophagocytic lymphohistiocytosis (HLH) and Epstein-Barr virus (EBV)-associated immune dysregulation remain poorly characterized. We describe a child with molecularly confirmed VPS45 deficiency complicated by profound hypersplenism, EBV reactivation, and hyperinflammatory features during hematopoietic stem cell transplantation (HSCT) evaluation.
Case Presentation Summary: A four-year-old Syrian girl with homozygous VPS45 c.991C>T (p.His331Tyr) presented with recurrent febrile neutropenia, transfusion-dependent pancytopenia, and progressive hepatosplenomegaly. She had recurrent Pseudomonas skin infections, including ecthyma gangrenosum; an older sibling with the same disorder had died following unsuccessful HSCT. During the latest admission she developed persistent fever, worsening cytopenias, and splenomegaly measuring 17.6 cm. Repeated packed red blood cell transfusions produced minimal hemoglobin increment, consistent with severe splenic sequestration. EBV PCR was 16,920 IU/mL; serology (VCA IgG, EBNA IgG and early antigen IgG positive, IgM negative) supported reactivation. Ferritin rose to 2,988 ng/mL. Persistent fever, splenomegaly and cytopenias prompted assessment for secondary HLH, but only four of eight HLH-2004 criteria were fulfilled, with interpretation confounded by chronic marrow failure and repeated transfusions. Bone marrow examination showed mild dysplasia without hemophagocytosis or myelodysplastic transformation. She later deteriorated with culture-negative inflammation and bronchopneumonic changes requiring broad-spectrum antibiotics. Double-dose blood-product transfusions improved hemoglobin recovery after standard transfusions had been ineffective. Intravenous immunoglobulin was administered. Multidisciplinary discussion considered splenectomy before HSCT to reduce sequestration and potentially improve engraftment, but surgery was deferred during ongoing transplant planning.
Learning Points Discussion: This case illustrates three practical challenges in VPS45 deficiency: severe hypersplenism can markedly reduce transfusion efficacy; EBV reactivation may coexist with hyperinflammatory features that overlap with baseline marrow failure and complicate HLH assessment; and transplant preparation may require individualized strategies balancing infection, splenic sequestration, and engraftment considerations. Close multidisciplinary monitoring for EBV-related complications and evolving HLH is important when clinical inflammation cannot be explained by infection alone.

